Literature DB >> 12504096

Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers.

Xavier Mascle1, Olivier Albagli, Claudie Lemercier.   

Abstract

The B-cell lymphoma 6 (BCL6) gene encodes a transcriptional repressor containing six C-terminal Krüppel-like zinc fingers. The zinc finger (ZF) cluster is necessary and sufficient for interaction with both DNA and several proteins and for nuclear targeting. However, the functional specificity of the six ZFs in these cellular roles is unknown. To characterize this domain, we mutated individually each ZF of BCL6. Our results reveal that mutation of the two N-terminal ZFs does not impair cognate DNA-binding, cellular localization of the protein nor the transcriptional repression capacity of BCL6. By contrast, mutation of any of the remaining ZFs abolishes the binding of BCL6 to DNA in vitro and the transrepressive function of the protein in vivo. Finally, none of the six mutations affect the interaction between BCL6 and class II histone deacetylases. Thus our experiments demonstrate that BCL6 uses each of the four C-terminus ZFs for binding to a target sequence while the two amino terminal fingers are likely engaged in other unknown function(s).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12504096     DOI: 10.1016/s0006-291x(02)02873-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.

Authors:  Jon E Ramsey; Joseph D Fontes
Journal:  Mol Immunol       Date:  2013-08-14       Impact factor: 4.407

Review 2.  BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint.

Authors:  Srividya Swaminathan; Cihangir Duy; Markus Müschen
Journal:  Trends Immunol       Date:  2013-12-10       Impact factor: 16.687

3.  Point mutation of 5' noncoding region of BCL-6 gene in primary gastric lymphomas.

Authors:  Da-Liu Min; Xiao-Yan Zhou; Wen-Tao Yang; Hong-Fen Lu; Tai-Ming Zhang; Ai-Hua Zhen; Pei-Zheng Cao; Da-Ren Shi
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Alternative splicing generates a short BCL6 (BCL6S) isoform encoding a compact repressor.

Authors:  Yulei Shen; Baosheng Ge; Himabindu Ramachandrareddy; Timothy McKeithan; Wing C Chan
Journal:  Biochem Biophys Res Commun       Date:  2008-08-21       Impact factor: 3.575

5.  Bcl6 mediates the development of T follicular helper cells.

Authors:  Roza I Nurieva; Yeonseok Chung; Gustavo J Martinez; Xuexian O Yang; Shinya Tanaka; Tatyana D Matskevitch; Yi-Hong Wang; Chen Dong
Journal:  Science       Date:  2009-07-23       Impact factor: 47.728

6.  Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Authors:  Grace Lin; Christopher R LaPensee; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Cell Endocrinol       Date:  2014-08-01       Impact factor: 4.102

7.  CtBP is an essential corepressor for BCL6 autoregulation.

Authors:  Lourdes M Mendez; Jose M Polo; J Jessica Yu; Melissa Krupski; B Belinda Ding; Ari Melnick; B Hilda Ye
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

8.  Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile.

Authors:  Kenneth J Oestreich; Sarah E Mohn; Amy S Weinmann
Journal:  Nat Immunol       Date:  2012-03-11       Impact factor: 25.606

9.  The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns.

Authors:  Kenneth J Oestreich; Albert C Huang; Amy S Weinmann
Journal:  J Exp Med       Date:  2011-04-25       Impact factor: 14.307

10.  Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms.

Authors:  Chuanxin Huang; Katerina Hatzi; Ari Melnick
Journal:  Nat Immunol       Date:  2013-03-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.